Skip to main content

Table 2 General practice profile

From: The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems

General practice profile

 

Control (n = 7)

Intervention (n = 8)

Total (n = 15)

Location

Rural

3 (43%)

2 (25%)

5 (33%)

Urban

2 (29%)

3 (38%)

5 (33%)

Mixed

2 (29%)

3 (38%)

5 (33%)

Health Information System

EMIS (NI only)

2 (29%)

0 (0%)

2 (13%)

Vision (NI only)

1 (14%)

4 (50%)

5 (33%)

Helix (ROI only)

2 (29%)

1 (12%)

3 (20%)

Socrates (ROI only)

2 (29%)

0 (0%)

2 (13%)

HealthOne (ROI only)

0 (0%)

3 (38%)

3 (20%)

Number of full-timea GPs mean (SD)

 

2.9 (0.90)

2.1 (1.1)

2.5 (1.1)

Number of part-time GPs mean (SD)

 

2.1 (2.4)

1.3 (± 1.0)

1.7 (1.8)

Number of GP Session/practice mean (SD)

 

44 (21)

23 (8.7)

33 (19)

Number of practice nurse session/practice mean (SD)

 

14 (8.6)

9.0 (3.4)

11 (6.7)

GP practice size (number of patients registered)

 < 2,500

0 (0%)

1 (12%)

1 (7%)

 > 2,500 < 5,000

2 (29%)

5 (62%)

7 (47%)

 > 5,000 < 7,500

0 (0%)

1 (12%)

1 (7%)

 > 7,500

5 (71%)

1 (12%)

6 (40%)

Repeat prescribing policy

Yes

5 (71%)

6 (75%)

11 (73%)

No

2 (29%)

2 (25%)

4 (27%)

Time spent on repeat prescribing as per practice policy mean (SD)b

 

34 (± 16)

45 (± 35)

40 (± 28)

Routine medication review

Usually not

4 (57%)

6 (75%)

10 (67%)

Almost always

3 (43%)

2 (25%)

5 (33%)

Annual face-face medication review

Almost always

5 (71%)

7 (88%)

12 (80%)

Usually not

2 (29%)

1 (12%)

3 (20%)

  1. a Pragmatically decided as per GP practice
  2. b As per checklists